Triple Therapy with Exenatide/Pioglitazone/Metformin vs. Conventional Therapy: Changes in Liver Fibrosis Scores after 2 Years of Treatment in Patients with New-Onset Type 2 Diabete... by Lavrynenko, Olga, Abdul-Ghani, Muhammad, Alatrach, Mariam, Puckett, Curtiss, Adams, John, Alkhouri, Naim, DeFronzo, Ralph

Get full text

Type 2 diabetes subgroups and response to glucose‐lowering therapy: Results from the EDICT and Qatar studies by Abdul‐Ghani, Tamam, Puckett, Curtiss, Migahid, Osama, Abdelgani, Siham, Migahed, Ayman, Adams, John, Triplitt, Curtis, DeFronzo, Ralph, Jayyousi, Amin, Abdul‐Ghani, Muhammad

Get full text

Insulin secretion is a strong predictor for need of insulin therapy in patients with new‐onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study by Abdelgani, Siham, Puckett, Curtiss, Adams, John, Triplitt, Curtis, DeFronzo, Ralph A., Abdul‐Ghani, Muhammad

Get full text

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for t... by Lavynenko, Olga, Abdul‐Ghani, Muhammad, Alatrach, Mariam, Puckett, Curtiss, Adams, John, Abdelgani, Siham, Alkhouri, Naim, Triplitt, Curtis, Clarke, Geoffrey D., Vasquez, Juan A., Li, Jinqi, Cersosimo, Eugenio, Gastaldelli, Amalia, DeFronzo, Ralph A.

Get full text

1.8 Initial Triple Combination Therapy is Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed T2DM (72-OR) by Abdul-Ghani, Muhammad A., Puckett, Curtiss, Adams, John, Cersosimo, Eugenio, Triplitt, Curtis, Defronzo, Ralph A.

Get full text